• Roche received FDA 510(k) clearance for its cobas eplex respiratory pathogen panel 3.
• The test detects up to 19 viruses and bacteria, delivering results in under two hours.
• Up to five customizable panel configurations allow laboratories to tailor testing to local patient needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611020930PR_NEWS_USPR_____DE86066) on November 02, 2026, and is solely responsible for the information contained therein.